Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Shareholder Meeting (June 2020)
19 slides from Trendlines's shareholder meeting presentation, Jun 17, 2020
Slide 1: The Trendlines Group AGM presentation
The Trendlines Group AGM presentation Steve Rhodes Todd Dollinger Haim Brosh Chairman and CEO Chairman and CEO Chief Financial Officer 17 June 2020 SGX:42T OTCQX: TRNLY
Slide 2: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 3: Welcome
Welcome Contact details for any technical difficulties during the call: E-mail: shira@trendlines.com SMS or WhatsApp: +972.50.877.7013 3
Slide 4: Business highlights
Business highlights
Slide 5: Portfolio value expansion
Portfolio value expansion US$ millions Portfolio value with exit proceeds 140 120 Portfolio value (excluding consolidated subsidiaries) 100 Cumulative exit proceeds 80 60 40 20 0 31.12.08 31.12.09 31.12.10 31.12.11 31.12.12 31.12.13 31.12.14 31.12.15 31.12.16 31.12.17 31.12.18 31.12.19 Note: Portfol
Slide 6: 2020 business highlights
2020 business highlights • ApiFix Ltd. acquired by OrthoPediatrics Corp. • Trendlines Agrifood Fund Pte. Ltd. completed 3 investments. • OrthoSpin Ltd. raised US$5 million with Johnson & Johnson as lead investor. • 3 agrifood companies launched sales despite COVID-19 limitations. • 22 companies rais
Slide 7: ApiFix Ltd. acquisition by OrthoPediatrics Corp.
ApiFix Ltd. acquisition by OrthoPediatrics Corp. On 2 April 2020, we announced: • the 100% acquisition of portfolio company ApiFix Ltd. (“ApiFix”) • a portfolio company focused on non-fusion treatment of progressive adolescent idiopathic scoliosis • Minimum 17X Return on Investment, 39% Internal Rat
Slide 8: Acquisition terms
Acquisition terms Milestones Total consideration Trendlines’ consideration At closing 934,783 new common OP shares + 187,257 shares + US$150,000 US$0.8 million in cash Current share value** - US$ 8.9 million Earlier of 150 US$13 million (at least 25% in cash) ~ US$ 2,420,600** surgeries or 2nd anniv
Slide 9: Financial highlights
Financial highlights
Slide 10: Key value components
Key value components Change in portfolio value during FY2019 Balance sheet as at 31 December 2019 (US$ millions) 19.4 (3.6) (2.7) 21.1 (14.5) (15.5) (1.6) 97.2 102.8 99.8 Net portfolio Investments and Fair value Net portfolio Cash, short-term Fair value of Deferred Deferred tax** Payables & Total eq
Slide 11: Statements of financial position: assets
Statements of financial position: assets STATEMENTS OF FINANCIAL POSITION U.S. dollars in thousands GROUP 31 Dec 2019 31 Dec 2018 Audited Audited ASSETS Current assets Cash & cash equivalents 18,366 8,136 Short-term investments & Restricted 293 2,728 Accounts & other receivables 724 605 Short-term l
Slide 12: Statements of financial position: liabilities and equity
Statements of financial position: liabilities and equity STATEMENTS OF FINANCIAL POSITION U.S. dollars in thousands GROUP 31 Dec 2019 31 Dec 2018 Audited Audited LIABILITIES AND EQUITY Current liabilities Lease liability 428 Trade and other payables 2,145 1,745 Deferred revenues 2,148 3,630 Total Cu
Slide 13: Statements of financial position: liabilities and equity
Statements of financial position: liabilities and equity STATEMENTS OF FINANCIAL POSITION U.S. dollars in thousands GROUP 31 Dec 2019 31 Dec 2018 Audited Audited LIABILITIES AND EQUITY Equity Equity attributable to equity holders of the Company: Share capital 2,123 1,601 Share premium 79,289 65,282
Slide 14: Consolidated condensed report of income
Consolidated condensed report of income CONSOLIDATED STATEMENTS OF PROFIT OR LOSS U.S. dollars in thousands 12 months ended 31 Dec 2019 31 Dec 2018 (Audited) (Audited) Income Gain (loss) from change in fair value of investments in Portfolio Companies 3,753 (6,046) Income from services to Portfolio C
Slide 15: Consolidated condensed report of income
Consolidated condensed report of income CONSOLIDATED STATEMENTS OF PROFIT OR LOSS 12 months ended U.S. dollars in thousands 31 Dec 2019 31 Dec 2018 (Audited) (Audited) Expenses Operating, general and administrative expenses 7,062 6,395 Marketing expenses 269 404 R&D expenses, net 1,114 1,057 Financi
Slide 16: Growth drivers
Growth drivers 1 14 companies in commercialization 2 22 companies raised investments to further milestone achievements 3 Covid-19 highlighted need for health and food innovation 16
Slide 17: SGX: 42T OTCQX: TRNLY www.trendlines.com
SGX: 42T Steve Rhodes, Chairman & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chairman & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Haim Brosh, Chief Financial Officer haim@trendlines.com June 2020
Slide 18: Annual General Meeting announcement: issuer and securities
REPL::ANNUAL GENERAL MEETING::VOLUNTARY Issuer & Securities Issuer/ Manager THE TRENDLINES GROUP LTD. Security THE TRENDLINES GROUP LTD. - IL0011328858 - 42T Announcement Details Announcement Title Annual General Meeting Date &Time of Broadcast 17-Jun-2020 12:22:02 Status Replacement Announcement Re
Slide 19: Event dates and venues
Event Dates Meeting Date and Time 17/06/2020 13:00:00 Response Deadline Date 15/06/2020 13:00:00 Event Venue(s) Place Venue(s) Venue details Meeting The adjourned AGM will be held by electronic means. Therefore shareholders will not be Venue able to attend the Adjourned AGM in person. Attachments 1.
The Trendlines Group — Shareholder Meeting (June 2020) on 6ix